Person

Geoffrey Martha

Chairman and CEO · Director, Medtronic

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$17.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Oct 15, 2026MDTSale50,000$95.00$4.8M
Jun 7, 2024MDTSale17,519$83.76$1.5M
Jun 7, 2024MDTSale1,594$83.82$134K
Aug 25, 2021MDTSale10,100$132.67$1.3M
Aug 25, 2021MDTSale1,481$132.67$196K
Jun 28, 2021MDTSale11,500$125.29$1.4M
Apr 5, 2021MDTSale2,404$118.83$286K
Apr 5, 2021MDTSale9,308$118.83$1.1M
Jun 6, 2019MDTSale11,000$96.05$1.1M
Sep 24, 2018MDTSale49,799$97.93$4.9M
Jul 15, 2016MDTSale3,766$88.26$332K

SEC reporting-owner ID (CIK) 1560409 · all filings on EDGAR

Geoffrey Martha (MDT, NEE) | USBoard